GNLX
Genelux Corporation
NASDAQ · USHealthcareBiotechnology
$2.81-1.92%
Price as of Jul 20, 2026
GNLX ownership
Genelux Corporation ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$77.9K
Insider trades by month Buys Sells
May
Dec
Mar
May
Jun
Jul
Context3-month price +1.1%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Smither John Wdirector | Sell | 12,000 | $2.91 |
| Jun 18, 2026 | Zindrick Thomasofficer: President and CEO | Grant | 730,601 | — |
| Jun 18, 2026 | Thomas Johndirector | Grant | 28,409 | — |
| Jun 18, 2026 | Thomas Johndirector | Grant | 31,566 | $3.03 |
| Jun 18, 2026 | Mirabelli Marydirector | Grant | 28,409 | — |
| Jun 18, 2026 | Mirabelli Marydirector | Grant | 31,566 | $3.03 |
| Jun 18, 2026 | Yu Yongofficer: Chief Scientific Officer | Grant | 119,318 | — |
| Jun 18, 2026 | Smither John Wdirector | Grant | 28,409 | — |
| Jun 18, 2026 | Smither John Wdirector | Grant | 31,566 | $3.03 |
| Jun 18, 2026 | Tyree James Ldirector | Grant | 31,566 | $3.03 |
| Jun 18, 2026 | Pulisic Matthewofficer: Chief Financial Officer | Grant | 278,906 | — |
| Jun 18, 2026 | Groen Ericofficer: General Counsel | Grant | 233,957 | — |
| Jun 18, 2026 | Cappello Josephofficer: Chief Technical Officer | Grant | 174,841 | — |
| Jun 18, 2026 | Tyree James Ldirector | Grant | 28,409 | — |
| Jun 4, 2026 | Smalling Ralphofficer: Head of Regulatory | Sell | 192 | $2.93 |
| Jun 2, 2026 | Thomas Johndirector | Sell | 10,000 | $2.98 |
| May 12, 2026 | Cappello Josephofficer: Chief Technical Officer | Sell | 605 | $2.97 |
| May 12, 2026 | Yu Yongofficer: Chief Scientific Officer | Sell | 605 | $2.97 |
| May 12, 2026 | Smalling Ralphofficer: Head of Regulatory | Sell | 270 | $2.98 |
| May 12, 2026 | Zindrick Thomasofficer: President and CEO | Sell | 2,798 | $2.94 |
| Mar 26, 2026 | Cappello Josephofficer: Chief Technical Officer | Sell | 906 | $2.42 |
| Mar 26, 2026 | Smalling Ralphofficer: Head of Regulatory | Sell | 345 | $2.42 |
| Mar 26, 2026 | Zindrick Thomasofficer: President and CEO | Sell | 3,582 | $2.42 |
| Mar 26, 2026 | Yu Yongofficer: SVP, Clinical Development | Sell | 906 | $2.42 |
| Mar 26, 2026 | Smalling Ralphofficer: Head of Regulatory | Sell | 240 | $2.51 |
| Mar 3, 2026 | Thomas Johndirector | Sell | 10,000 | $2.90 |
| Jan 7, 2026 | Litten Jasonofficer: Chief Medical Officer | Grant | 275,000 | $4.55 |
| Dec 11, 2025 | Yu Yongofficer: SVP, Clinical Development | Sell | 973 | $5.37 |
| Dec 11, 2025 | Cappello Josephofficer: Chief Technical Officer | Sell | 1,463 | $3.36 |
| Dec 11, 2025 | Cappello Josephofficer: Chief Technical Officer | Sell | 1,270 | $3.33 |
Source: GNLX SEC Form 4 filings, latest Jul 2, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their GNLX positions over the last 6 months (SEC Form 13F).
Increased
38
New positions
29
Reduced
27
Sold out
26
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | Increased | 2.1M | Apr 24, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.7M | May 15, 2026 |
| VANGUARD GROUP INC | Increased | 1.6M | Jan 29, 2026 |
| BLEICHROEDER LP | Increased | 1.4M | May 14, 2026 |
| BLEICHROEDER LP | Unchanged | 714K | Feb 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 454K | May 15, 2026 |
| BLACKROCK, INC. | Increased | 406K | May 13, 2026 |
| BLACKROCK, INC. | Increased | 385K | Feb 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 381K | Feb 9, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 336K | Feb 17, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 324K | May 18, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 323K | Feb 3, 2026 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | Increased | 303K | Feb 9, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | Unchanged | 285K | Feb 13, 2026 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | Reduced | 281K | May 5, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.